FDA clears Pear Therapeutics' mobile app to help treat opioid abuse

The U.S. Food and Drug Administration on Monday cleared Pear Therapeutics' mobile application to help increase retention of patients undergoing outpatient treatment for opioid abuse.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.